Levetiracetam in nonconvulsive status epilepticus in a child with angelman syndrome

Journal of Child Neurology

Volumn 25, Issue 3, 2010, Pages 393-396

  Weber, Peter ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Angelman syndrome; Intravenous levetiracetam; Nonconvulsive status epilepticus

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CARNITINE; ETIRACETAM; GAMMA GLUTAMYLTRANSFERASE; LAMOTRIGINE; PHENOBARBITAL; VALPROIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALERTNESS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHILD; CHILDHOOD DISEASE; CHROMOSOME ANALYSIS; CLINICAL EXAMINATION; DEVELOPMENTAL DISORDER; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG POTENTIATION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EPILEPTIC DISCHARGE; EPILEPTIC STATE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE DELETION; HAPPY PUPPET SYNDROME; HUMAN; LIVER DISEASE; MALE; NEUROIMAGING; NONCONVULSIVE EPILEPTIC STATE; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; VOMITING;

ANGELMAN SYNDROME; ANTICONVULSANTS; BRAIN; CHILD; ELECTROENCEPHALOGRAPHY; HUMANS; MALE; PIRACETAM; STATUS EPILEPTICUS; TREATMENT OUTCOME;

EID: 77649265413     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073809338626     Document Type: Article

References (14)

1. Maganti R., Gerber P., Drees C., Chung S. Non-convulsive status epilepticus. Epilepsy Behav. 2008 ; 12 (4). 572-586.
2. Korff CM, Nordli DR Diagnosis and management of nonconvulsive status epilepticus in children. Nat Clin Pract Neurol. 2007 ; 3 (9). 505-516.
3. Treiman DM, Walker MC Treatment of seizure emergencies: convulsive and non-convulsive status epilepticus. Epilepsy Res. 2006 ; 68 (suppl 1). S77 - S82.
4. Pelc K., Boyd SG, Cheron G., Dan B. Epilepsy in Angelman syndrome. Seizure. 2008 ; 17 (3). 211-217.
5. Galván-Manso M., Campistol J., Conill J., Sanmarti FX Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of Angelman Syndrome. Epileptic Disord. 2005 ; 7 (1). 19-25.
6. Ohtsuka Y., Kobayashi K., Yoshinaga H., et al. Relationship between severity of epilepsy and developmental outcome in Angelman Syndrome. Brain Dev. 2005 ; 27 (2). 95-100.
7. Knake S., Gruener J., Hattemer K., et al. Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry. 2008 ; 79 (5). 588-589.
8. Atef R., Tettenborn B. Non-convulsive status epilepticus on treatment with levetiracetam. Epilepsy Behav. 2005 ; 6 (4). 613-616.
9. Goraya JS, Khurana DS, Valencia I., et al. Intravenous levetiracetam in children with epilepsy. Pediatric Neurol. 2008 ; 38 (3). 177-180.
10. Michaelides C., Thibert RL, Shapiro M., et al. Tolerability and dosing experience of intravenous levetiracetam in children and infants. Epilepsy Res. 2008 ; 81 (2-3). 143-147.
11. Gallentine WB, Hunnicutt AS, Husain AM Levetiracetam in children with refractory status epilepticus. Epilepsy Behav. 2009 ; 14: 215-218.
12. Trabacca A., Profice P., Constanza MC, Gesualdi M., De Rinaldis M. Levetiracetam in nonconvulsive status epilepticus in childhood: a case report. J Child Neurol. 2007 ; 22 (5). 639-641.
13. Alehan F., Ozcay F., Haberal M. The use of levetiracetam in a child with non-convulsive status epilepticus. J Child Neurol. 2008 ; 23 (3). 331-333.
14. Dion MH, Novotny EJ Jr, Carmant L., Cossette P., Nguyen DK Lamotrigine therapy of epilepsy with Angelmans syndrome. Epilepsia. 2007 ; 48 (3). 593-596.